Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Thoracic 1Myeloid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Myelodysplastic Syndromes 92Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Leukemia, Myeloid, Acute 79Leukemia 41Myeloproliferative Disorders 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Multiple Myeloma 21Leukemia, Myeloid, Chronic-Phase 20Lymphoma, Non-Hodgkin 18Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Leukemia, Myelomonocytic, Chronic 16Polycythemia Vera 14Hodgkin Disease 14Primary Myelofibrosis 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms, Plasma Cell 10Lymphoma, Follicular 10Hematologic Neoplasms 10Burkitt Lymphoma 10Recurrence 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Anemia, Refractory, with Excess of Blasts 9Myelodysplastic-Myeloproliferative Diseases 8Mastocytosis, Systemic 8Mastocytosis 8Lymphoma, Mantle-Cell 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Accelerated Phase 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Virus Diseases × Myeloid × Clear all
NCT05066958 2021-10-04

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 1/2 Unknown
20 enrolled
LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Virus Diseases, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡